Is SNPX or DVY a better dividend investment in 2026?

SNPX currently yields 25.48% with a 5% 5-year dividend growth rate. DVY yields 3.50% with 5% growth. The better choice depends on your goal: SNPX offers higher current income.

What is the dividend yield difference between SNPX and DVY?

SNPX has a forward dividend yield of 25.48% ($2.00/share annually). DVY yields 3.50% ($5.25/share annually). The yield gap is 21.98 percentage points.

Home › Compare › SNPX vs DVY

SNPX vs DVY: Dividend Comparison 2026

SNPX yields 25.48% · DVY yields 3.50%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 DVY wins by $683.00 in total portfolio value· pulled ahead in Year 9

INVESTMENT

TIME HORIZON10 years

SNPX

● Live price

25.48%

Share price

$7.85

Annual div

$2.00

5Y div CAGR

-50%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$24.4K

Annual income

$3.08

Full SNPX calculator →

DVY

● Live price

3.50%

Share price

$150.03

Annual div

$5.25

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.1K

Annual income

$437.78

Full DVY calculator →

Portfolio growth — SNPX vs DVY

📍 DVY pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SNPX	DVY
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SNPX + DVY cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SNPX pays

DVY pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SNPX

Annual income on $10K today (after 15% tax)

$2,165.61/yr

After 10yr DRIP, annual income (after tax)

$2.62/yr

DVY

Annual income on $10K today (after 15% tax)

$297.17/yr

After 10yr DRIP, annual income (after tax)

$372.11/yr

At 15% tax rate, DVY beats the other by $369.49/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SNPX + DVY for your $10,000?

SNPX: 50%DVY: 50%

100% DVY50/50100% SNPX

Portfolio after 10yr

$24.7K

Annual income

$220.43/yr

Blended yield

0.89%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on SNPX right now

SNPX

Analyst Ratings

Buy

Consensus: Buy

Altman Z

-3.0

Piotroski

0/9

DVY

No analyst data

Altman Z

307.5

Piotroski

1/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SNPX buys

DVY buys

No recent congressional trades found for SNPX or DVY in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSNPXDVY

Forward yield	25.48% ✓	3.50%
Annual dividend / share	$2.00	$5.25 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	-50%	0% ✓
Portfolio after 10y	$24.4K	$25.1K ✓
Annual income after 10y	$3.08	$437.78 ✓
Total dividends collected	$2.7K	$4.0K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: SNPX vs DVY ($10,000, DRIP)

Year	SNPX Portfolio	SNPX Income/yr	DVY Portfolio	DVY Income/yr	Gap
1	$11,974	$1,273.89	$11,050	$349.62	+$924.00 → SNPX
2	$13,525	$712.77	$12,184	$361.04	+$1.3K → SNPX
3	$14,848	$376.21	$13,409	$372.07	+$1.4K → SNPX
4	$16,080	$193.00	$14,730	$382.68	+$1.4K → SNPX
5	$17,303	$97.67	$16,154	$392.89	+$1.1K → SNPX
6	$18,564	$49.11	$17,688	$402.69	+$876.00 → SNPX
7	$19,888	$24.62	$19,338	$412.07	+$550.00 → SNPX
8	$21,292	$12.33	$21,113	$421.04	+$179.00 → SNPX
9← crossover	$22,789	$6.17	$23,020	$429.61	$231.00 → DVY
10	$24,387	$3.08	$25,070	$437.78	$683.00 → DVY

SNPX vs DVY: Complete Analysis 2026

SNPX — Stock

Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and Niemann-pick type C disease. Synaptogenix, Inc. has licensing agreements with Stanford University; Icahn School of Medicine at Mount Sinai; and The Board of Trustees of the Leland Stanford Junior University. The company was incorporated in 2012 and is headquartered in New York, New York.

Full SNPX Calculator →

DVY — ETF

The iShares Select Dividend ETF seeks to track the investment results of an index composed of relatively high dividend paying U.S. equities.

Full DVY Calculator →

📬

Get this SNPX vs DVY comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SNPX vs SCHD SNPX vs JEPI SNPX vs O SNPX vs KO SNPX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.